164 related articles for article (PubMed ID: 8516879)
21. [Influence of intravenous steroid administration on kidney function].
Pinggera WF
Fortschr Med; 1976 Mar; 94(9):493-6. PubMed ID: 786841
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal effects of cyclosporine administration at 0 to 60 months after heart transplantation.
Costanzo MR; Beto JA; Potempa LD; Bansal VK; Heroux AL; Kao WG; Pifarre R; Johnson MR
Transplant Proc; 1994 Oct; 26(5):2704-9. PubMed ID: 7940847
[No Abstract] [Full Text] [Related]
23. Predicting glomerular filtration rate in heart transplant recipients using serum creatinine-based equations with cimetidine.
Tangri N; Alam A; Giannetti N; Deedwardes MB; Cantarovich M
J Heart Lung Transplant; 2008 Aug; 27(8):905-9. PubMed ID: 18656805
[TBL] [Abstract][Full Text] [Related]
24. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.
De Meester JM; Van Vlem B; Walravens M; Vanderheyden M; Verstreken S; Goethals M; Kerre N; Wellens F
Transplant Proc; 2005 May; 37(4):1835-8. PubMed ID: 15919481
[TBL] [Abstract][Full Text] [Related]
25. A comparison of different methods of estimating glomerular filtration rate in cyclosporine-treated renal transplant patients.
Germain MJ; Lipkowitz GS; Guarnera J; Fiorentino J
Transplantation; 1993 Jan; 55(1):203-5. PubMed ID: 8420049
[No Abstract] [Full Text] [Related]
26. Cyclosporine-induced transient renal hypoperfusion in adolescent transplant recipients.
Dello Strologo L; Massella L; Rizzoni G
Pediatr Nephrol; 1996 Feb; 10(1):81-3. PubMed ID: 8611366
[TBL] [Abstract][Full Text] [Related]
27. What is cyclosporine nephrotoxicity?
Myers BD
Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
[No Abstract] [Full Text] [Related]
28. Renal, hemodynamic and neurohormonal effects of atrial natriuretic factor in cardiac allograft recipients treated with cyclosporin A.
Lang CC; Choy AM; Pringle TH; McNeill GP; McAlpine HM; Sturrock ND; Struthers AD
Am J Cardiol; 1993 Nov; 72(14):1083-4. PubMed ID: 8213592
[No Abstract] [Full Text] [Related]
29. [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Hottelart C; el Esper N; Achard JM; Pruna A; Fournier A
Nephrologie; 1999; 20(1):41-4. PubMed ID: 10081035
[TBL] [Abstract][Full Text] [Related]
30. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
Heidrich VH; Baethke R; Beyer KH
Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
[TBL] [Abstract][Full Text] [Related]
31. Switching immunosuppression from cyclosporine to tacrolimus improves long-term kidney function: a 6-year study.
Hohage H; Welling U; Zeh M; Gerhardt U; Suwelack B
Transplant Proc; 2005 May; 37(4):1898-9. PubMed ID: 15919497
[TBL] [Abstract][Full Text] [Related]
32. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
33. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients.
Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C
Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261
[No Abstract] [Full Text] [Related]
34. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients.
Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK
Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168
[No Abstract] [Full Text] [Related]
35. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
[TBL] [Abstract][Full Text] [Related]
36. Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients.
Mueller EA; Kallay Z; Kovarik JM; Arns W; Renner E; Kutz K
Transplant Proc; 1995 Feb; 27(1):834-6. PubMed ID: 7879198
[No Abstract] [Full Text] [Related]
37. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center.
Tinawi M; Miller L; Bastani B
Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of low-dose cyclosporine on renal function in normal subjects.
Fuiano G; Sepe V; Cianfrone P; Libetta C; Sabbatini M; Colucci G; Conte G; Balletta M; De Nicola L
Transplantation; 1991 Mar; 51(3):734-6. PubMed ID: 2006535
[No Abstract] [Full Text] [Related]
39. Lipid abnormalities in red blood cell and plasma phospholipids in cyclosporine-treated heart transplant recipients.
Phair PG; Powell HR; McCredie DA
Transplant Proc; 1994 Dec; 26(6):3722-6. PubMed ID: 7998329
[No Abstract] [Full Text] [Related]
40. Intrarenal blood oxygenation and renal function measured by magnetic resonance imaging during long-term cyclosporine treatment.
Kristensen DH; Pedersen M; Grøn MC; Flyvbjerg A; Madsen M; Frøkiaer J; Mortensen J
Transplant Proc; 2005 Oct; 37(8):3302-4. PubMed ID: 16298580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
